Search

everythinglearnresearchcommunity

for

Search:↓

Synthetic cannabinoid addiction can cause skin problems like acne and hair loss.

Phenobarbitone can cause severe and sometimes fatal skin reactions.

Testosterone therapy is effective and safe for women with low sexual desire, but it's hard to access.

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.

Fluoxetine's effectiveness as an antidepressant in mice depends on a specific protein activity and a 5-minute pretest.

Some skin medications are safe for pregnant women, but others pose risks or should not be used.

Environmental stressors like UV radiation, pollution, and extreme temperatures can damage skin and lead to diseases and aging.

High proliferative activity and peripheral invasion indicate malignancy in canine sebaceous gland tumors; the term 'epithelioma' should be updated for clarity.

Use some skin medications with caution during pregnancy; avoid strong steroids, certain eczema treatments, and systemic retinoids, but many topical treatments and nasal sprays are safe.

Stress, nutritional issues, and chronic diseases can cause hair loss, and nail changes may signal internal diseases; treatment focuses on the underlying cause.

Systemic lupus erythematosus treatment can restore vision in patients with retinal artery occlusion.

Telogen Effluvium is a hair loss condition where treatment involves identifying and managing its triggers.

Skin problems are common in Lupus patients and can indicate the disease's severity, requiring specific treatments and lifestyle changes.

Anifrolumab effectively improved lupus headaches in a patient unresponsive to other treatments.

Gene therapy shows promise for treating skin disorders and cancer, but faces technical challenges.

Rosemary essential oil can improve mood, sleep, and cognitive function but may cause allergies, so use it carefully.

Anifrolumab may help improve symptoms in patients with overlapping autoimmune diseases.

Early diagnosis and thorough evaluation are crucial for better outcomes in alopecic sarcoidosis.

Dexamethasone-primed stem cell media shows promise in treating lupus by reducing symptoms and inflammation.

Anifrolumab treatment improves quality of life and reduces disease activity and steroid use in SLE patients.

Histone modification is key in treating chronic inflammatory skin diseases.

Non-scarring hair loss is common in lupus patients and can be diagnosed with specific hair and tissue tests.

Efficient delivery systems are needed for the clinical use of CRISPR-Cas9 gene editing.

Most patients with Cutaneous Lupus Erythematosus are young females, and dermatologists play a key role in diagnosis.

The Polish Dermatological Society recommends personalized treatment for cutaneous lupus, including lifestyle changes, medications, and monitoring, with specific drugs for severe cases.

Antioxidants may help improve mitochondrial health and could be used to treat diseases related to cell damage.

The document concludes that managing skin conditions during pregnancy is important and requires specialized care.

The document concludes that permanent hair loss conditions are complex, require early specific treatments, and "secondary permanent alopecias" might be a more accurate term than "secondary cicatricial alopecia."

Certain inhibitors applied to the skin can promote hair growth by maintaining a key hair growth signal.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.